TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 130 filers reported holding TCR2 THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $119,000 | -93.0% | 43,123 | -88.2% | 0.00% | -100.0% |
Q4 2021 | $1,700,000 | +171.1% | 364,726 | +395.0% | 0.00% | – |
Q3 2021 | $627,000 | -32.9% | 73,686 | +29.3% | 0.00% | -100.0% |
Q2 2021 | $935,000 | -24.7% | 56,990 | +1.4% | 0.00% | 0.0% |
Q1 2021 | $1,241,000 | -29.6% | 56,200 | -1.3% | 0.00% | 0.0% |
Q4 2020 | $1,762,000 | +52.3% | 56,952 | +0.0% | 0.00% | 0.0% |
Q3 2020 | $1,157,000 | +45.9% | 56,947 | +10.3% | 0.00% | 0.0% |
Q2 2020 | $793,000 | +162.6% | 51,629 | +32.4% | 0.00% | – |
Q1 2020 | $302,000 | -35.5% | 39,006 | +19.1% | 0.00% | – |
Q4 2019 | $468,000 | -4.9% | 32,745 | +0.1% | 0.00% | – |
Q3 2019 | $492,000 | -1.8% | 32,720 | -6.6% | 0.00% | – |
Q2 2019 | $501,000 | +1.2% | 35,044 | +23.5% | 0.00% | – |
Q1 2019 | $495,000 | – | 28,372 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 4,050,865 | $11,748,000 | 4.96% |
MPM BioImpact LLC | 3,370,982 | $9,776,000 | 2.72% |
TANG CAPITAL MANAGEMENT LLC | 3,641,606 | $10,561,000 | 1.60% |
Newtyn Management, LLC | 692,799 | $2,009,000 | 0.38% |
K2 PRINCIPAL FUND, L.P. | 1,078,070 | $3,126,000 | 0.34% |
HARBOR CAPITAL ADVISORS, INC. | 64,341 | $187,000 | 0.14% |
Redmile Group, LLC | 1,094,645 | $3,174,000 | 0.12% |
Artal Group S.A. | 750,000 | $2,175,000 | 0.12% |
Oasis Management Co Ltd. | 200,000 | $580,000 | 0.10% |
X-Square Capital, LLC | 31,919 | $93,000 | 0.06% |